Instructions for Authors

Read full text Summarise with VIRAT
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Aims and scope Journal aims Promote multidisciplinary collaboration: To highlight and advance the role of multidisciplinary teams (MDTs) in the diagnosis, treatment, and management of cardio-oncology patients, fostering a holistic and patient-centered approach to care. Disseminate cutting-edge research: To publish high-quality, innovative research that spans the entire spectrum of cardio-oncology, from basic and translational science to clinical studies and outcomes research. Educate healthcare professionals: To provide comprehensive knowledge that supports the continuous professional development of all members of the MDT, including cardiologists, oncologists, radiologists, surgeons, nurses, and allied health professionals. Address global health disparities: To promote research and practices that address health disparities in cardio-oncology care, ensuring equitable access to the latest advancements in diagnosis, treatment, and prevention worldwide. Promote patient-centered care: To emphasize the importance of involving patients and their families in treatment decisions and care planning, incorporating patient perspectives and experiences into the journal’s content. Disseminate knowledge through a diverse range of content formats, including original research articles, reviews, commentaries, patient case studies, interactive multimedia content, and sharing best practices tailored to different healthcare professionals within the cardio-oncology MDT. Journal scope The Journal of Cardio-Oncology welcomes submissions that cover a broad range of topics within the field, including but not limited to: Clinical research: Studies on the diagnosis, treatment, and management of cardiovascular complications in cancer patients, including clinical trials, case reports, and observational studies. Basic and translational science: Research on the underlying mechanisms of cardiotoxicity, biomarkers, and susceptibility to cardiovascular injury caused by cancer therapies. MDT approaches: Articles that showcase the benefits and challenges of MDTs in cardio-oncology, including best practices, protocols, and case studies, including clinical practice guidelines and clinical consensus statements. Innovative therapies and technologies: Research on new therapeutic strategies, emerging technologies, and interventions that improve the care of cardio-oncology patients (such as AI and precision medicine). Patient and family perspectives: Narratives and studies that highlight the experiences and outcomes of patients and their families, emphasizing the importance of patient-centered care (including psychosocial aspects of cancer and cardiovascular disease, including patient advocacy and support strategies). Health policy and advocacy: Discussions on healthcare policies, organizational strategies, and advocacy efforts that support the integration and effectiveness of MDTs in cardio-oncology. Global health: Research addressing the global disparities in cardio-oncology care, with a focus on innovative solutions for low- and middle-income countries. Educational resources: Educational articles, reviews, and multimedia content aimed at the continuous education and training of MDT members in the latest advancements and best practices in cardio-oncology. Online submission First-time users Please click the Register button at https://www.editorialmanager.com/jcardiooncol/. Upon successful registration, you will be sent an email providing your username and password. Save this information for future reference. Note: If you have received an email from us with an assigned username and password, or if you are a repeat user, do not register again. Once you have an assigned username and password, you do not have to re-register. Authors Please click the Login button from the menu at the top of the page and login to the system as an author. Submit your manuscript according to the author instructions. You will be able to track the process of your manuscript through the system. Journal policies Duplicate publication Manuscripts are reviewed for possible publication with the understanding that they are being submitted only to the Journal of Cardio-Oncology and have not been published, simultaneously submitted, or already accepted for publication elsewhere. The editorial team may subject any manuscript submitted for consideration of publication in the Journal of Cardio-Oncology to plagiarism-detection software. This does not preclude consideration of a manuscript that has been rejected by another journal or a complete report that follows publication of preliminary findings elsewhere, usually in the form of an abstract. Copies of any possibly duplicate published material should be submitted with the manuscript under consideration, with a statement in the cover letter as to why the manuscript currently being submitted is not a duplicate publication. Authorship Journal of Cardio-Oncology expects that each person listed as an author has participated sufficiently in the intellectual content, the analysis of data, and/or the writing of the manuscript to take public responsibility for it. Each author must have reviewed the manuscript, believe it represents valid work, and approve it for submission. Moreover, should the Editorial team request the data upon which the manuscript is based, the authors shall produce it. Each author’s specific contributions to the work should be indicated; this information will be published as a footnote to the paper. For example, the areas of participation might include: Participated in research design. Participated in the writing or critical revision of the paper. Participated in the performance of the research. Contributed new reagents or analytic tools. Participated in data analysis. An author may list more than one contribution, and more than one author may have contributed to the same aspect of the work. Any change in authorship/contributions after submission must be approved in writing by all authors and submitted to the Editorial Office for final consideration. Plagiarism As defined by the World Association of Medical Editors (http://www.wame.org/resources/publication-ethics-policies-for-medical-journals), plagiarism is the use of others’ published and unpublished ideas or words (or other intellectual property) without attribution or permission, and presenting them as new and original rather than from an The and of plagiarism is to the as to the contributions of the This the ideas or words are from research or unpublished or published in any publication or Journal of Cardio-Oncology is a of by and is a plagiarism that the of content submitted publication. submissions of published research and of content. and use to their work submission by of plagiarism are in with the on guidelines at plagiarism is at any or after the journal editorial will take as by the by If plagiarism is the the author’s and and the original publication will be statement the providing a to the and to the original may on the of the the may be For support and of Authors must all possible of in the manuscript, including and other that might to or a of If is of this should be as of should be in the of and of should be on the page of the manuscript with the of and of For of has received from is currently a from and is on the for the for For the of list all the for the is of the submission process and must be by each author at the This information is for by the Editors but will be published if to the content of the accepted The of the is to authors have received any support that a of to a for of or not an that a (such as or or Please for submitted to at the studies on authors should the in with the of the on or and with the of For studies involving authors are to of the or or from research and for in the The which be as and/or of by from or in on the or a research or any on the care and use of for by a and must be by the authors on should be as as and the of and should be The of must be in with the guidelines by the and World Medical Association of on for Medical Research and The journal will not any which is statement on and practices must be in all research under the the to publication of a after it has been accepted if it that are with the content or of Studies in and If the work the use of the author should that the work has been in with The of of the World Medical Association of for involving The manuscript should be in with the for the and of in Medical and for the of and as The and should be Authors should a statement in the manuscript that for with The of must be For studies involving and is and it should be in the that has been The which is may and/or Authors must the of and must not or Authors studies involving must have the by the to improve of ensuring that the data from be and Articles in must to the as a and authors to use the The information in guidelines should be in the of the of to information should not be published in and and the information is for and the patient (or or for publication. Authors should from they have from the The journal by not the the to have the patient form the publication to patient and have the form by the author. If the publication that the patients a statement the to be in the of clinical of clinical is an for publication of clinical in the Journal of the page of your manuscript, provide the of the and the of the clinical the at for at for The Clinical at at Clinical at Clinical any of clinical of clinical should the in the of statement this statement a and to improve the of of and a for to report guidelines Journal of Cardio-Oncology authors to the and other guidelines all guidelines from their Authors should be able to provide the by the editorial studies and Studies of Clinical practice guidelines research research and to data and and and and focus are to Authors are to the guidelines for research. Please and/or of studies provide a understanding of for of research and critical Authors to the statement at statement Journal of Cardio-Oncology authors to in any that report from research data to a data The of a data statement will be as a of publication. should information on data the in the be to or the research data are not this must be in the manuscript with any for the must take one of the (or a of more than one if for of research The and/or the are in the The and/or the are not but are from the author on The and/or the are from the author on sharing not to this as or the data or this are in this published information The data that support the findings of this are from but to the of data, which under for the and are not from the authors upon request and with of AI policy Authors use AI and in the writing of a manuscript, of or of the or in the and analysis of data, must be in in the manuscript which AI and it Authors are for the content of their submitted manuscript, including any by an AI and are for any of publication The specific AI and should be in the or AI For to the in for policy on AI use for authors and Journal of Cardio-Oncology a the and authors are of each on editorial process of the all submitted for for Manuscripts with or or a of a are rejected for Manuscripts that are to be of to the of the journal are to be rejected at this Manuscripts that are for publication of the journal are sent to a of to the of the Authors to the Journal of Cardio-Oncology may or may have The should not be with the same as the the of is at the of the to and have access to the submitted manuscript and any by the If the is a will have access to the in their on to publish an and authors and improve their for the published work that is not and provide to the authors and the Journal of are of are sent to the authors of including and are not are their publication. on the from the the an on the manuscript and the and in to the is to provide a to and a of the This process is and are with the Manuscripts are accepted on the of and importance for the Manuscripts received from editorial members will be by the and sent to The editorial to the journal as authors or will be from publication Manuscripts received from will be by the other or one of the of the journal and will be sent to The will be from the of Editors are not in decisions which they have or have been by family members or or to or in which the has an Any submission is subject to the journal’s with of the and their research for should have in the as in their research and publication will be for under the of and be in the editorial and of all in the should to the editorial and publication policies as for the as of a all should to the same as any journal paper. This that each manuscript will be not be published in a and will be reviewed by at in the The follows best practice by the to the of and the final decisions to all The authors have the to if they have a to believe that the editorial has rejected the paper. If the authors to the editorial they should email the editorial in the for the The will be by the editorial and will be in an The of will be within under the manuscript should not be submitted to other The final with the of the are not of published Editorial to words more than Research is authors are to be more than and Each should be and in for should the for should the Authors must from to published elsewhere. As on the of for comprehensive of and more than and As As and As As As to words As As As Medical words and more than words not As As and As As The of should not be than usually with to words not to words more than and/or As more than Clinical to words As more than and/or As The of should be more than including and As As on report more than words As As more than Clinical solutions to words of and more than for As of or to words As or more than submissions for that the of or on in or policy in cardio-oncology. should be to words with more than research: Manuscripts of original research including or clinical studies. are in that findings with should advancements in the field, new or that to the understanding of cardio-oncology. is on manuscript authors are to be within Each should a of to and is on the of for comprehensive of submissions of that report the of and of data from studies. that provide a comprehensive of and on Manuscripts should be with a of words and should focus on presenting and the of the with an on and to the of should be more than and Medical should highlight or emerging that have the to clinical practice or research. The MDT a of in Manuscripts be or and should be and words in and should emphasize the and of the advancements providing for and and The of the Journal of Cardio-Oncology as a for clinical practice and by professional The journal in on or Authors are to a or that the and The of or clinical research that has not must the research and including and should to the statement and the as the final of the abstract. Journal of Cardio-Oncology welcomes of any and a or to and The Journal of submissions of of the including and that and data in as diagnosis, or and The is limited to words including and If you have a your within the scope of the the journal’s the same and editorial process as original research are of original studies. should not words with more than and/or and Clinical Authors of provide their experiences for diagnosis, treatment or prevention of clinical in the cardio-oncology MDT The is to words with more than and/or and are and the should be words including and Authors of this of should their are Authors usually one to patients or a The is limited to more than words and to Clinical The are of and to be with clinical or will be Articles in this should the case clinical strategies, clinical and author’s The is limited to words and a of and for Authors provide with of or This is to the of and that is not as a for case to a Journal of Cardio-Oncology should be received within of the publication and should not words of and should be submitted and Manuscripts must be in Manuscripts not to journal will be to authors for Please the entire and each not as the system will the is Research Articles should the listed of AI The page must include: of the should and the of the and the or The of all authors and at the the research if of support for the with of the role of if any in and of writing of the any the submission of the report for or a statement that the or publication. of and list any an author and a in the submitted manuscript or the author and any or the research in the submitted If an author has of list the author’s by of is under Journal of author’s and and is for the editorial of the submitted and must a that more than is in complete and the one or that the of the the the specific to be or the including the use of or the specific and if analysis if the including of in one or the outcomes of the including their clinical if the or Clinical and it provide a to the the and for or An for and is Please that does not for of studies. articles, and and case should an more than that the of the and the and Any in the should be defined in the at the provide or including the subject that will to the of your do not use that are to your manuscript but are not in your manuscript or are to to by as Please that manuscript you will be to to the in for your for should the to your manuscript and may from your list of for publication. the to the research and the specific This should not be a comprehensive of the the specific and the of the not data, or from the work being The should and the studies on authors should the in with the of the on or and with the of as in at For studies involving authors are to of or or from research and for in the The which be as and/or of by from including or in on authors must that all in with guidelines and For the and of authors are to the Medical Association for the of The guidelines is studies. for by a as as must be by the authors on The of must be in with the guidelines by the and the World Medical Association of on for Medical Research for studies involving and The journal will not any which is statement on and practices must be in all research under the and of your of the observational or or including including and and a of the information the the and address in and in to other to the to including provide and for that have been published but are not new or for and their all and including and of of clinical should information on all including the of interventions of of to treatment and the of on the your in a in the and not of data more than and do not duplicate data from or in the not data from for to (such as from a clinical for the of each or For rather than not the or the not or should be to for to more than does not If it should be as rather than or for of studies, it may be to to more Please the of for If for example, it should be as the aspects of the and the that from not repeat in data or other material in the or the of the findings and their and the to other studies. and to work that has not been new and by the and them as This should the of the from the and within the in the should the if or presenting new data, or not with the of the and and that are not by the only have contributions to the and may be only in this statement Authors must provide a statement that the research in with For studies, this the of the that and the as as a that from all For studies, it should with and guidelines for the care and use of including the from the of authors must any of of of and or other must be at the of your manuscript and in a that must be on submission. you use the form to you this If are of of in this to to for work by the and the Association is from a or other to a or other research the of the or that the If has been for the the research not any specific from in the or statement should information on data the in the be to or the the Journal for more contributions the contributions of each to the may include: data writing original writing and and listed authors should the journal’s AI statement If AI or in the of the manuscript, authors must this in a The statement should the AI for data and that the authors take responsibility for the and should be in the in which they are in the and should be in in the list should all Any within the and for the of the manuscript should be if by the editorial The journal the Medical Association should on a page and be in the in which they are in the they are by and and and published and that have been accepted for publication should be listed in the Manuscripts in unpublished and should be to in in the submitted for publication may be as to the If are the author may them to the in more than authors should be If are or only the by should be of journal must be and of journal should to For information on of through than in and as of of the on after and Each should be and in for should the for should the Please that it is the responsibility of the to from the to or that have been published elsewhere. of are not each (including and on a may be as of the and after the the in in and a for each Each in the should a the data in the to and the the to which they are in the in Each should be able to be without the should be a and may be within the or not more than in the and in for do not or and should be in the should be for all are to with the and on a for any being submitted are to be not into the final for accepted should be submitted in or is the is Each must be as a must be in (such as should be at a of or should be at a of and should be at must be as as are not for manuscript may be to you for if the are of submitted to the journal will be for Authors a will have the to the of their and the This is for all content Authors may to the information in the is to all and in the manuscript, is not a on the of in this may the of to information as and should be in the of the submitted will be at the within the and are not by the that journal policies for manuscript submission to patient and to Authors should and from content they from the patients and them as at the of manuscript submission. and must be in one or Each in the should have a in the and and a must in the that is from If providing a should be on the as the For and the author’s and should be with a For each the a of use of the is a for publication in the Journal of Authors in writing in to from or the in their and challenges to a to a paper. To the of authors in with a range of editorial to you a and of to of journal complete and to you a with your in your and will it into as as it to that it publication Plagiarism that your manuscript of Save and by ensuring that your is by the journal without you to the of software. For more information that the use of a is at the author’s and and does not that the will be Online manuscript submission submissions Once the manuscript has been the submission at to the Once the manuscript has been for to the journal’s a manuscript will be assigned to the submission. to to guidelines will in your manuscript being to you for or of will not be submissions author Upon authors will be to complete a are of author listed on the submission. Please each author’s email address is listed on the page of your manuscript to in Manuscripts will not to without are from the submission https://www.editorialmanager.com/jcardiooncol/. submissions a to the Please this as a to in the manuscript should be or a and a of the are for of all is the as and should be submitted within the in the Please us for an of the if it is not possible to the revision within that or should you to the manuscript from consideration. should to the original for the submission in to the may the manuscript of the and/or with original This may be by the but must be in the Authors may or be to to the journal’s The will to emphasize aspects of the research findings in their to be published Please to and for The Journal will you page are for your The on the author’s are Please the Journal if you have any the of the on the For information or the of publication of your accepted manuscript, the editorial in author’s information Please all new including email to the editorial and to the Authors may this information to the editorial If the journal is in the the author will not for and the manuscript may not be at is that the final manuscript sent to the is the final should be at The journal is the of all to any published in the access research in this journal will be published This that the is and the in in an after publication. The journal does not for or publication of and for of The journal will to the the of the will be published under the For and the and to in a work (such as an as as they the and provide they do not or the of Health The journal is with the Please to the page for more Editorial The editorial is to any you may have your manuscript in with Any Submit a

Fields of Study & Subjects

Chemotherapy-induced cardiotoxicity and mitigation Academic Writing and Publishing Cardiac tumors and thrombi

Publication details

Journal / source
Journal of Cardio-oncology
Volume
2
Issue
1
Pages
32–41
Publication date
1 March 2026
Language
EN